Per ulteriori informazioni selezionare i riferimenti di interesse.
Slowing down ALS - is this good or bad?
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome
JOURNAL OF THE NEUROLOGICAL SCIENCES
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis
NEUROEPIDEMIOLOGY
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome - Reply
NEUROLOGY
The ALS Patient Care Database - Goals, design, and early results
NEUROLOGY
The global burden of disease study - Implications for neurology
ARCHIVES OF NEUROLOGY
How continuing medical education can change everyday neurological practice
EUROPEAN JOURNAL OF NEUROLOGY
Association of cigarette smoking with amyotrophic lateral sclerosis
NEUROEPIDEMIOLOGY
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)
MUSCLE & NERVE
The relationship of lower-limb muscle force to walking ability in patientswith amyotrophic lateral sclerosis
PHYSICAL THERAPY
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome
NEUROLOGY
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
NEUROLOGY
Consensus guidelines far the design and implementation of clinical trials in ALS
JOURNAL OF THE NEUROLOGICAL SCIENCES
MUTATIONS IN THE GLUTAMATE TRANSPORTER EAAT2 GENE DO NOT CAUSE ABNORMAL EAAT2 TRANSCRIPTS IN AMYOTROPHIC-LATERAL-SCLEROSIS
Annals of neurology
PILOT-STUDY OF MYOBLAST TRANSFER IN THE TREATMENT OF BECKER MUSCULAR-DYSTROPHY
Neurology
LOWER-EXTREMITY MUSCLE FORCE MEASURES AND FUNCTIONAL AMBULATION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Archives of physical medicine and rehabilitation
LEAD-EXPOSURE AND AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
American journal of epidemiology
EFFECT OF INCREASED MAXILLOMANDIBULAR RELATIONSHIP ON ISOMETRIC STRENGTH IN TMD PATIENTS WITH LOSS OF VERTICAL DIMENSION OF OCCLUSION
Cranio
MUTATIONS IN GLUTAMATE TRANSPORTER GENE (EAAT2) IN AMYOTROPHIC-LATERAL-SCLEROSIS
Annals of neurology
INTRATHECAL ADMINISTRATION OF RECOMBINANT HUMAN SUPEROXIDE-DISMUTASE-1 IN AMYOTROPHIC-LATERAL-SCLEROSIS - A PRELIMINARY SAFETY AND PHARMACOKINETIC STUDY
Neurology
CHARACTERIZATION OF SURVIVAL MOTOR-NEURON (SMN(T)) GENE DELETIONS IN ASYMPTOMATIC CARRIERS OF SPINAL MUSCULAR-ATROPHY
Human molecular genetics
TOXICITY AND TOLERABILITY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Neurology
DEVELOPMENT OF MEASUREMENT TECHNIQUES
Neurology
DEVELOPMENT OF MEASUREMENT TECHNIQUES - DISCUSSION
Neurology
CLINICAL-TRIALS OF RILUZOLE IN PATIENTS WITH ALS
Neurology
ISSUES IN CLINICAL-TRIAL DESIGN .1. USE OF NATURAL-HISTORY CONTROLS -A PROTAGONIST VIEW
Neurology
COMMUNICATIONS AND ALS TRIAL - INFORMATION SHARING
Neurology
DYSTONIC POSTURES GENERATED FROM COMPLEX REPETITIVE DISCHARGES
Neurology
A COMPARISON OF 3 MEASURES OF DISEASE PROGRESSION IN ALS
Journal of the neurological sciences
MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA
Archives of physical medicine and rehabilitation
SMA CONSORTIUM - SUMMARY OF MEETING (CLINICAL AND PLENARY MEETINGS), 4-6-MARCH-1994, NAARDEN, THE NETHERLANDS
Neuromuscular disorders
ANALYSIS OF INTRATHECAL (IT) ADMINISTRATION OF HUMAN RECOMBINANT SUPEROXIDE-DISMUTASE (RHSOD1) IN SHEEP AS A THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
Neurology
LINKAGE OF MIYOSHI MYOPATHY (DISTAL AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY) LOCUS TO CHROMOSOME 2P12-14
Neurology
WORLD-FEDERATION-OF-NEUROLOGY-RESEARCH GROUP ON NEUROMUSCULAR DISEASES SUBCOMMITTEE ON MOTOR-NEURON DISEASE - AIRLIE-HOUSE GUIDELINES - THERAPEUTIC TRIALS IN AMYOTROPHIC-LATERAL-SCLEROSIS - SUBCOMMITTEE ON MOTOR-NEURON DISEASES OF THE WORLD-FEDERATION-OF-NEUROLOGY RESEARCH GROUPON NEUROMUSCULAR DISEASES AND THE AIRLIE-HOUSE THERAPEUTIC TRIALS IN ALS WORKSHOP CONTRIBUTORS
Journal of the neurological sciences
ANALYSIS OF THE SURVIVAL MOTOR-NEURON (SMN) GENE IN SPINAL MUSCULAR-ATROPHY FAMILIES
American journal of human genetics
LINKAGE DISEQUILIBRIUM AND HAPLOTYPE ANALYSIS AMONG POLISH FAMILIES WITH SPINAL MUSCULAR-ATROPHY
American journal of human genetics
NEUROLOGISTS VARY IN THE DIAGNOSTIC-TESTS THEY ORDER TO EVALUATE DEMENTIA
Journal of the American Geriatrics Society
INTERNATIONAL SMA CONSORTIUM - SUMMARY OF MEETING HELD 30 APRIL 2 MAY1993, CAMBRIDGE-MARRIOTT-HOTEL
Neuromuscular disorders
HIGH-DOSE DEXTROMETHORPHAN IN AMYOTROPHIC-LATERAL-SCLEROSIS - PHASE-ISAFETY AND PHARMACOKINETIC STUDIES
Annals of neurology
THE AAN LAUNCHES A NEW EDUCATION-PROGRAM - CONTINUUM LIFELONG LEARNING IN NEUROLOGY
Neurology
NEUROMUSCULAR DISEASE - EDITORIAL OVERVIEW
Current opinion in neurology
A MODEL FOR REDUCING SAMPLE-SIZE IN AMYOTROPHIC-LATERAL-SCLEROSIS THERAPEUTIC TRIALS
Annals of neurology
SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Annals of neurology
RECOMBINANT GROWTH-HORMONE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS
Muscle & nerve
THE NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS AND THE USE OF NATURAL-HISTORY CONTROLS IN THERAPEUTIC TRIALS
Neurology
ASSESSMENT OF NONALLELIC GENETIC-HETEROGENEITY OF CHRONIC (TYPE-II AND TYPE-III) SPINAL MUSCULAR-ATROPHY
Human heredity